The first procedure in the world designed to treat a patient using a bioengineered external liver was recently performed by a team at Intermountain Medical Center.

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

An FDA study of 110 melatonin supplements marketed for children found doses ranged from 0 to 667 percent of the amount on the ...

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

United Therapeutics Corporation (NASDAQ: UTHR) is one of the most undervalued US stocks according to analysts. On June 24, ...

United Therapeutics Corporation made $24.64 a share (GAAP) on $2.88 billion in FY2024. The current analyst firm consensus has profits increasing to $27.68 a share as sales climb to $3.22 billion ...

United Therapeutics UTHR shares soared 3.5% in the last trading session to close at $286.14. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

United Therapeutics had a net margin of 40.31% and a return on equity of 19.22%. The firm had revenue of $794.40 million for the quarter, compared to analyst estimates of $726.82 million.

Following these transactions, Mahon holds 36,781 shares of United Therapeutics common stock. The sales were executed under a pre-arranged 10b5-1 trading plan, which was established on December 24 ...

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies ...